<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00569920</url>
  </required_header>
  <id_info>
    <org_study_id>s8197.04</org_study_id>
    <secondary_id>S-04189</secondary_id>
    <nct_id>NCT00569920</nct_id>
  </id_info>
  <brief_title>Nausea and Pain Prophylaxis During Thyroid Surgery</brief_title>
  <official_title>Nausea and Pain Prophylaxis During Thyroid Surgery, a Comparison of Low-Dose and High-Dose Dexamethasone to Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sykehuset Telemark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sykehuset Telemark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pain and nausea may diminish a patient`s wellbeing, and may also delay
      rehabilitation, as well as increase the total cost of care and treatment. Opioids are
      effective drugs for treatment of pain, but with the disadvantage of side effects such as
      somnolence and nausea. The benefits of various types of non-opioid analgesic in reducing
      patients` postoperative need for opioids have been well-documented.

      One non-opioid prophylaxis documented for various surgery is short-term treatment with
      corticosteroids. The optimal dose of corticosteroids for peroperative nausea and pain
      prophylaxis is not well-documented. In our study we will attempt to determine whether the
      aforementioned benefits of corticosteroids are valid for a group of patients undergoing
      thyroid surgery.

      Hypothesis: Single-dose treatment with dexamethasone provides a better analgesic effect
      and/or reduced use of opioids than placebo in patients undergoing elective throid surgery.
      Higher dose of dexamethasone provide better and/or longer-lasting analgesic effects without
      influencing the side effect profile.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain (VAS) and use of opioids. Nausea.</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nausea</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Thyroid Diseases</condition>
  <condition>Parathyroid Diseases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexamethasone &quot;low-dose&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone &quot;high-dose&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexamethasone</intervention_name>
    <description>IV dexamethasone 0,15 mg/kg bodyweight. Single-dose bolus injection after start of anesthesia. Medication is opened and administrated to the patient from a coded ampoule by the physician. The medication is diluted in such a way that 1 mL is equivalent to 10 kg body weight (1,5 mg/mL).</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Fortecortin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>natriumchloride 0,9%</intervention_name>
    <description>iv natriumchloride 0,9% (placebo). 1 mL is equivalent to 10 kg body weight.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexamethasone</intervention_name>
    <description>IV dexamethasone 0,30 mg/kg body weight. Drug diluted to 3,0 mg/mL and administrated in same way as arm 2.</description>
    <arm_group_label>3</arm_group_label>
    <other_name>fortecortin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inpatients scheduled for elective thyroid surgery and parathyroid surgery under
             general anesthesia.

          -  Informed consent

        Exclusion Criteria:

          -  Patients who use steroids

          -  Patients who use antiemetics

          -  Patients who use opioid analgesics

          -  Body weight &gt; 100 kg

          -  BMI &gt; 35
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johan Raeder, Prof. M.D</last_name>
    <role>Study Director</role>
    <affiliation>Ullevål university hospital, Oslo university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Surgery Unit, Porsgrunn, Acute Care Clinic, Telemark Hospital</name>
      <address>
        <city>Porsgrunn</city>
        <state>Telemark</state>
        <zip>3919</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2007</study_first_submitted>
  <study_first_submitted_qc>December 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2007</study_first_posted>
  <last_update_submitted>January 14, 2009</last_update_submitted>
  <last_update_submitted_qc>January 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Simen Doksrød/Acting chief physician</name_title>
    <organization>Sykehuset Telemark</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Parathyroid Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

